| 引用本文：孙静.制定并落实目标全面的国家药物政策：印度经验与教训[J].中国卫生政策研究,2009,2(6):36-38 |
|
| 制定并落实目标全面的国家药物政策：印度经验与教训 |
| 投稿时间：2009-05-16 修订日期：2009-05-30 PDF全文浏览 HTML全文浏览 |
| 孙静 |
| 世界卫生组织驻华代表处 |
| 摘要:中国和印度同为经济崛起中的大国, 在全球医药市场中起着举足轻重的作用。世界上绝大多数价格低廉的通用名药都是由这两个国家生产供应的，但这两个国家的国民却在不同程度上面临着获得有质量保证基本药物的挑战。药品的经济学和社会学属性，医药领域的健康目标和经济发展目标，如何平衡医药产业的发展对经济和社会作出的贡献等问题，在这两个国家都存在着热议。本文回顾印度国家药物政策的历史演变过程，剖析其产生的矛盾效果：培育了强大的民族医药产业，但本国多数民众基本用药仍得不到保障。文章还分析印度德里地区制定、贯彻和落实区域药物政策的成功经验，希望为中国制定目标全面的国家药物政策和建立国家基本药物制度提供有益的经验和教训。 |
| 关键词:基本药物 基本药物制度 国家药物政策 |
|
| How to formulate and implement national medicines policy: experiences and lessons learnt from India for China |
| SUN Jing |
| WHO Representative Office in China |
| Abstract:China and India, the two big emerging economies have been taking a center stage in the global pharmaceutical market, and playing an important role in offering low cost generics to the world, but both facing the same challenge of equal access to affordable and quality essential medicines to its own people. There have been hot debates in both countries about the commercial and social characters of medicines, the objective of the pharmaceutical sector, and how to balance the economic and social benefits from the industrial development. This article reviews the evolution of Indians national pharmaceutical policy, discusses how they have been fostering a strong pharmaceutical industry, but having limit impact on improving the health of the Indian people. In addition, it analyses the successfulness of the Delhi Model in formulating, implementation and enforcement of its state pharmaceutical policy, hope to make a reference for China in developing its national pharmaceutical policy and establishing its national essential medicines system. |
| Key words:Essential medicines, Essential medicines system, National medicines policy |
| 摘要点击次数: 3395 全文下载次数: 4368 |
|
|
